Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Bart JF van den Bemt"'
Autor:
Nathan den Broeder, Aatke van der Maas, Alfons A den Broeder, Bart JF van den Bemt, Frank HJ van den Hoogen, Yael A de Man, Marc R Kok, Lise Verhoef, Rogier Thurlings, Wilfred van der Weele
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Background The REDO trial (REtreatment with Rituximab in RhEmatoid arthritis: Disease Outcome after Dose Optimisation) showed similar disease activity for retreatment with ultralow doses (200 mg and 500 mg per 6 months) compared with standard low-dos
Externí odkaz:
https://doaj.org/article/12646c2bca3040469a48a59a6f5fa167
Autor:
Melissa F Djodikromo, Rosella PMG Hermens, Bart JF van den Bemt, Yolba Smit, Tim M Govers, Charlotte L Bekker, Nicole MA Blijlevens
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Dose reduction of tyrosine kinase inhibitors (TKI) in patients with chronic myeloid leukaemia (CML) with an optimal response to TKIs may support cost-effective medication use by maintaining therapeutic effectiveness while reducing
Externí odkaz:
https://doaj.org/article/660c43c24cb144448a2c018c9ee34ecb
Autor:
Bart PH Pouls, Charlotte L Bekker, Sandra van Dulmen, Johanna E Vriezekolk, Bart JF van den Bemt
Publikováno v:
JMIR Serious Games, Vol 10, Iss 1, p e31570 (2022)
BackgroundPatients’ implicit attitudes toward medication need and concerns may influence their adherence. Targeting these implicit attitudes by combining game-entertainment with medication-related triggers might improve medication adherence in pati
Externí odkaz:
https://doaj.org/article/62b0d8a468ff49659b1e4232c97802e6
Autor:
Loes JM van Herpen-Meeuwissen, Hein AW van Onzenoort, Patricia MLA van den Bemt, Barbara Maat, Bart JF van den Bemt
Publikováno v:
NARCIS
Dove Medical Press
ORCID
Patient Preference and Adherence, 16, 2683-2693. DOVE MEDICAL PRESS LTD
Patient Preference and Adherence, 16, 2683-2693
Patient Preference and Adherence, 16, pp. 2683-2693
Dove Medical Press
ORCID
Patient Preference and Adherence, 16, 2683-2693. DOVE MEDICAL PRESS LTD
Patient Preference and Adherence, 16, 2683-2693
Patient Preference and Adherence, 16, pp. 2683-2693
Loes JM van Herpen-Meeuwissen,1,2 Hein AW van Onzenoort,1,3 Patricia MLA van den Bemt,4 Barbara Maat,2 Bart JF van den Bemt1,5 1Department of Pharmacy, Radboud University Medical Centre, Radboud Institute for Health Sciences, Nijmegen, the Netherland
Autor:
Renske CF Hebing, Marry Lin, Maja Bulatovic Calasan, Ittai B Muller, Sohaila Mahmoud, Sandra Heil, Eduard A Struys, Bart JF van den Bemt, Jos WR Twisk, Willem Lems, Michael T Nurmohamed, Gerrit Jansen, Robert de Jonge
Publikováno v:
Hebing, R C, Lin, M, Bulatovic Calasan, M, Muller, I B, Mahmoud, S, Heil, S, Struys, E A, van den Bemt, B J, Twisk, J W, Lems, W, Nurmohamed, M T, Jansen, G & de Jonge, R 2022, ' Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis : the methotrexate monitoring trial ', Annals of the Rheumatic Diseases . https://doi.org/10.1136/ard-2022-223398
Annals of the Rheumatic Diseases. BMJ Publishing Group
Annals of the Rheumatic Diseases, 82(4):223398, 460-467. BMJ Publishing Group
Annals of the Rheumatic Diseases. BMJ Publishing Group
Annals of the Rheumatic Diseases, 82(4):223398, 460-467. BMJ Publishing Group
ObjectiveTo investigate the pharmacokinetics of methotrexate polyglutamate (MTX-PG) accumulation in red blood cells (RBCs) and peripheral blood mononuclear cells (PBMCs) in patients with early rheumatoid arthritis (RA) after oral and subcutaneous MTX
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4fed2cdd72bcbd6fd00e20f59d9939f
https://research.vumc.nl/en/publications/6f32a105-afa2-4d5b-b018-d70e76db34a3
https://research.vumc.nl/en/publications/6f32a105-afa2-4d5b-b018-d70e76db34a3
Autor:
Jeffrey van der Ven, Bart JF van den Bemt, Johanna E Vriezekolk, Liset van Dijk, Merel Opdam, Lex L Haegens, Lise M Verhoef
BACKGROUND Implementation of digital hospital services (DHS), defined as digital technologies for use by patients offered by the hospital, is progressing slowly. In-depth insight into patients’ preferences and needs regarding DHS might improve its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63586212c482750ee563b7b0b298dddc
https://doi.org/10.2196/preprints.44885
https://doi.org/10.2196/preprints.44885
Autor:
Bart PH Pouls, Charlotte L Bekker, Sandra van Dulmen, Johanna E Vriezekolk, Bart JF van den Bemt
BACKGROUND Patients’ implicit attitudes toward medication need and concerns may influence their adherence. Targeting these implicit attitudes by combining game-entertainment with medication-related triggers might improve medication adherence in pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::737d69bd853daa431c18cdba674d5c4b
https://doi.org/10.2196/preprints.31570
https://doi.org/10.2196/preprints.31570
Autor:
Milou, van Heuckelum, Elke Ge, Mathijssen, Marcia, Vervloet, Annelies, Boonen, Renske Cf, Hebing, Annelieke, Pasma, Harald E, Vonkeman, Mark H, Wenink, Bart Jf, van den Bemt, Liset, van Dijk
Publikováno v:
Patient preference and adherence
Background Although patients have different treatment preferences, these individual preferences could often be grouped in subgroups with shared preferences. Knowledge of these subgroups as well as factors associated with subgroup membership supports
Autor:
Lise M Verhoef, Bart JF van den Bemt, Aatke van der Maas, Johanna E Vriezekolk, Marlies E Hulscher, Frank HJ van den Hoogen, Wilco CH Jacobs, Noortje van Herwaarden, Alfons A den Broeder
Publikováno v:
Cochrane Database of Systematic Reviews, 5, Cd010455
The Cochrane Library
Cochrane Database of Systematic Reviews, 5, pp. Cd010455
Cochrane Database of Systematic Reviews, 9, CD010455
Cochrane Database Syst Rev
Cochrane Database of Systematic Reviews, 9, 9, pp. CD010455
The Cochrane Library
Cochrane Database of Systematic Reviews, 5, pp. Cd010455
Cochrane Database of Systematic Reviews, 9, CD010455
Cochrane Database Syst Rev
Cochrane Database of Systematic Reviews, 9, 9, pp. CD010455
BACKGROUND: Anti–tumour necrosis factor (TNF) agents are effective in treating people with rheumatoid arthritis (RA), but are associated with (dose‐dependent) adverse effects and high costs. To prevent overtreatment, several trials have assessed